MedTrace Logo

The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

NCT02029599 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2015-10-09

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of Fang yi qing Feng shi granules in subjects with Rheumatoid Arthritis.

Conditions

Interventions

DRUG

Fang yi qing feng shi granule

10g, Oral,Three each time, 3 times a day,for 3 months;

DRUG

placebo

10g, Oral,Three each time, 3 times a day,for 3 months

DRUG

Methotrexate

7.5-15mg per week，All patients should be used

DRUG

Acetaminophen tablets

Oral,0.5g, 1\~2 times a day, when vas=10

Sponsors & Collaborators

  • Maoxiang Group Jilin Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • wei liu · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029599 on ClinicalTrials.gov